Cookie policy notice

By continuing to use this site you agree to our cookies policy below:
Since 26 May 2011, the law now states that cookies on websites can ony be used with your specific consent. Cookies allow us to ensure that you enjoy the best browsing experience.

This site is intended for health professionals only

At the heart of general practice since 1960

BNF highlights eGFR failures

The updated BNF will highlight the shortcomings of the estimated glomerular filtration rate calculation for predicting renal disease in patients at extremes of body weight.

The September edition of the BNF will warn that while GPs should use eGFR to estimate the degree of renal function impairment in patients in the normal weight range, the calculation provides anomalous results at either extreme.

Instead, the formulary advises GPs that in patients at both extremes of weight the creatinine clearance should be used, or the dose adjusted according to plasma-drug concentration and clinical response.

Dr Donal O'Donoghue, the Government's renal tsar and a consultant nephrologist at the Hope Hospital in Salford, Manchester, explained that creatinine clearance calculations were ‘normalised' to account for body surface area, whereas eGFR calculations were not.

This, he estimated, could lead to a difference of 10-15% in patients at extremes of the body surface area continuum.

Using eGFR calculations in these patients 'would imply that their renal function is more impaired than it is, which may lead to overdiagnosis of renal disease'.

Rate this article 

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Have your say